Diaceutics (GB:DXRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Diaceutics PLC has announced board changes, with Cheryl MacDiarmid and Jordan Clark joining as Non-Executive and Executive Directors, respectively, while Mike Wort resigns. Graham Paterson will take on the role of Senior Independent Director. These strategic appointments aim to leverage the new members’ extensive experience in the pharmaceutical sector to drive Diaceutics’ growth and performance.
For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.